XENT Intersect ENT, Inc. Stock Quote

XENT [NASD]

Index	-	P/E	-	EPS (ttm)	-1.85	Insider Own	2.40%	Shs Outstand	32.70M	Perf Week	4.43%
Market Cap	750.81M	Forward P/E	-	EPS next Y	-1.33	Insider Trans	0.00%	Shs Float	31.68M	Perf Month	-0.63%
Income	-60.10M	PEG	-	EPS next Q	-0.32	Inst Own	92.10%	Short Float	2.99%	Perf Quarter	19.76%
Sales	84.10M	P/S	8.93	EPS this Y	-81.10%	Inst Trans	3.05%	Short Ratio	4.02	Perf Half Y	23.29%
Book/sh	2.49	P/B	9.57	EPS next Y	31.10%	ROA	-37.90%	Target Price	23.00	Perf Year	-2.10%
Cash/sh	4.15	P/C	5.74	EPS next 5Y	7.60%	ROE	-60.60%	52W Range	5.97 - 26.98	Perf YTD	4.02%
Dividend	-	P/FCF	-	EPS past 5Y	3.20%	ROI	-38.40%	52W High	-11.71%	Beta	1.65
Dividend %	-	Quick Ratio	7.40	Sales past 5Y	23.10%	Gross Margin	65.70%	52W Low	298.99%	ATR	1.43
Employees	402	Current Ratio	7.90	Sales Q/Q	-5.80%	Oper. Margin	-70.00%	RSI (14)	49.67	Volatility	6.89% 5.46%
Optionable	Yes	Debt/Eq	0.77	EPS Q/Q	14.10%	Profit Margin	-71.50%	Rel Volume	1.09	Prev Close	22.95
Shortable	Yes	LT Debt/Eq	0.77	Earnings	Mar 09 BMO	Payout	-	Avg Volume	235.46K	Price	23.82
Recom	2.40	SMA20	-1.22%	SMA50	-0.16%	SMA200	26.87%	Volume	256,972	Change	3.79%

Jan-11-21

Upgrade

Canaccord Genuity

Hold → Buy

$25

Nov-19-20

Upgrade

BTIG Research

Neutral → Buy

$32

Oct-08-20

Downgrade

JP Morgan

Overweight → Neutral

$19

Aug-07-20

Upgrade

Guggenheim

Neutral → Buy

$30

Jun-24-20

Initiated

Oppenheimer

Perform

May-12-20

Downgrade

Canaccord Genuity

Buy → Hold

Apr-15-20

Downgrade

BofA/Merrill

Buy → Underperform

$28 → $10

Aug-02-19

Downgrade

Piper Jaffray

Overweight → Neutral

$30 → $17

Aug-02-19

Downgrade

Guggenheim

Buy → Neutral

Jul-10-19

Upgrade

Northland Capital

Under Perform → Market Perform

$20

Jun-21-19

Downgrade

Berenberg

Buy → Hold

May-07-19

Downgrade

SVB Leerink

Outperform → Mkt Perform

$29

May-07-19

Downgrade

Northland Capital

Market Perform → Under Perform

$28 → $20

Apr-20-18

Initiated

Berenberg

Buy

Jan-02-18

Upgrade

JP Morgan

Neutral → Overweight

May-31-17

Downgrade

Northland Capital

Outperform → Market Perform

May-03-17

Reiterated

Wedbush

Outperform

$25 → $26

Dec-07-16

Initiated

Guggenheim

Buy

$20

Nov-02-16

Downgrade

JP Morgan

Overweight → Neutral

Oct-06-16

Initiated

Deutsche Bank

Hold

$17

Mar-05-21 09:59AM	Why Earnings Season Could Be Great for Intersect ENT (XENT) Zacks
Mar-03-21 05:10AM	What Does Intersect ENT, Inc.'s (NASDAQ:XENT) Share Price Indicate? Simply Wall St.
Mar-02-21 12:30PM	Intersect ENT (XENT) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Feb-23-21 04:05PM	Intersect ENT to Report Fourth Quarter and Full Year 2020 Financial Results Business Wire
Feb-11-21 07:00AM	Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL® Mini Sinus Implant Business Wire
Feb-01-21 04:05PM	Intersect ENT to Participate in Upcoming Investor Conferences Business Wire
Jan-26-21 08:22AM	Does Intersect ENT's (NASDAQ:XENT) Share Price Gain of 47% Match Its Business Performance? Simply Wall St.
Jan-19-21 07:00AM	Intersect ENT Announces CMS Approval of Coding Application for PROPEL® Sinus Implant Business Wire
Jan-18-21 09:41AM	Intersect ENT's (XENT) Q4 Preliminary Revenues Disappointing Zacks
Jan-12-21 07:00AM	Intersect ENT Announces Preliminary Revenue for Fourth Quarter of 2020 Business Wire +8.73%
Jan-05-21 08:00AM	CORRECTING and REPLACING - Intersect ENT to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-24-20 10:44AM	Intersect ENT (XENT) Banks on SINUVA Sales Amid COVID-19 Woes Zacks
06:29AM	An Intrinsic Calculation For Intersect ENT, Inc. (NASDAQ:XENT) Suggests It's 23% Undervalued Simply Wall St.
Dec-16-20 09:19AM	Is XENT A Good Stock To Buy Now? Insider Monkey
Dec-02-20 11:31AM	Intersect ENT (XENT) Up 17.6% Since Last Earnings Report: Can It Continue? Zacks
Nov-17-20 04:45PM	Intersect ENT Announces New Appointments to Executive Leadership Team Business Wire
Nov-05-20 04:05PM	Intersect ENT to Participate at Upcoming Investor Conferences Business Wire
Nov-04-20 02:18PM	Intersect ENT, Inc. (NASDAQ:XENT) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
08:20AM	Intersect ENT (XENT) Q3 Earnings and Revenues Beat Estimates Zacks
Nov-02-20 08:25AM	Intersect ENT: Q3 Earnings Insights Benzinga
08:25AM	Intersect ENT (XENT) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:00AM	Intersect ENT Reports Third Quarter 2020 Financial Results Business Wire
Oct-26-20 12:31PM	Intersect ENT (XENT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-20-20 09:27AM	Intersect ENT (XENT) Posts Preliminary Q3 Data, Dull Q4 View Zacks
Oct-16-20 07:15AM	The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs Benzinga
Oct-15-20 04:05PM	Intersect ENT Announces Preliminary Revenue for Third Quarter of 2020 Business Wire
Oct-09-20 08:00AM	Intersect ENT to Report Third Quarter 2020 Financial Results Business Wire
Oct-02-20 08:00AM	Intersect ENT Closes Acquisition of Fiagon AG Medical Technologies Business Wire
Sep-22-20 03:47PM	Is Intersect ENT (NASDAQ:XENT) Using Debt Sensibly? Simply Wall St.
Sep-15-20 08:00AM	Intersect ENT Announces Agreement to Acquire Fiagon AG Medical Technologies for 60 Million Paid Over Three Years Business Wire
Sep-11-20 09:51AM	Intersect ENT, AllianceRx Execute Pharmacy-Services Agreement Zacks
08:05AM	The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review Benzinga
Sep-10-20 05:30PM	Intersect ENT Announces Specialty Pharmacy Partnership Agreement with AllianceRx Walgreens Prime to Distribute SINUVA® Sinus Implant Business Wire
Sep-03-20 11:31AM	Why Is Intersect ENT (XENT) Down 1.2% Since Last Earnings Report? Zacks -5.85%
Aug-05-20 10:34AM	Intersect ENT (XENT) Q2 Loss Widens, Revenues Beat Estimates Zacks +8.07%
Aug-04-20 08:35AM	Intersect ENT (XENT) Reports Q2 Loss, Tops Revenue Estimates Zacks +10.17%
07:00AM	Intersect ENT Reports Second Quarter 2020 Financial Results Business Wire
Jul-28-20 12:33PM	Intersect ENT (XENT) Expected to Beat Earnings Estimates: Should You Buy? Zacks
11:11AM	Did Hedge Funds Make The Right Call On Intersect ENT Inc (XENT) ? Insider Monkey
Jul-22-20 04:05PM	Intersect ENT to Report Second Quarter 2020 Financial Results Business Wire
Jul-13-20 10:07AM	Implied Volatility Surging for Intersect ENT (XENT) Stock Options Zacks
Jul-08-20 03:52PM	Medtronic Is Said to Bid for Sinusitis Device Firm Intersect TheStreet.com +29.41%
11:30AM	Why Intersect ENT Stock Is Skyrocketing Today Motley Fool
07:31AM	The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy Benzinga
Jul-02-20 08:48PM	Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors' Losses? PR Newswire
Jun-23-20 03:01AM	Intersect ENT Announces Independent Analysis in UK Confirming Cost Effectiveness of PROPEL® Steroid Releasing Sinus Implant Following Sinus Surgery for Chronic Sinusitis Business Wire
Jun-22-20 12:10PM	Intersect ENT Inc (XENT): Hedge Funds Are Reducing Their Exposure Insider Monkey
08:10AM	Edited Transcript of XENT earnings conference call or presentation 11-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-11-20 11:16AM	Intersect ENT's Sinuva Adoption to Rise on New C-Code by CMS Zacks -9.75%
Jun-09-20 07:00AM	CMS Approves SINUVA® Sinus Implant for Reimbursement with New C-Code and Pass-Through Payment Status Business Wire +14.50%
Jun-03-20 07:32AM	Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors' Losses? PR Newswire +6.00%
May-26-20 04:15PM	Intersect ENT to Present at the William Blair 40th Annual Growth Stock Conference Business Wire +8.54%
May-14-20 09:28AM	Intersect ENT (XENT) Reports Wider-Than-Expected Q1 Loss Zacks
May-12-20 04:31AM	Intersect ENT (XENT) Q1 2020 Earnings Call Transcript Motley Fool -5.34%
May-11-20 08:25AM	Intersect ENT (XENT) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:38AM	Recap: Intersect ENT Q1 Earnings Benzinga
07:01AM	Intersect ENT Reports First Quarter 2020 Results Business Wire
07:00AM	Intersect ENT Announces $65 Million Convertible Notes Investment from Deerfield Management Business Wire
May-08-20 07:00AM	Intersect ENT Reschedules Time of First Quarter 2020 Financial Results Conference Call to 4:30 P.M. ET on May 11, 2020 Business Wire
May-07-20 04:05PM	Intersect ENT to Present at the 2020 Bank of America Merrill Lynch Global Healthcare Conference Business Wire
May-02-20 09:15AM	Did You Acquire XENT Before August 1, 2018? Johnson Fistel Continues its Investigation of Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses? GlobeNewswire
Apr-28-20 04:05PM	Intersect ENT to Report First Quarter 2020 Financial Results Business Wire
Apr-27-20 12:32PM	Earnings Preview: Intersect ENT (XENT) Q1 Earnings Expected to Decline Zacks
Apr-20-20 09:02AM	Moving Average Crossover Alert: Intersect ENT Zacks +5.75%
Apr-15-20 08:26AM	Intersect Posts Preliminary Q1 Results, Withdraws '20 View Zacks -9.71%
Apr-13-20 04:15PM	Intersect ENT Announces Preliminary Revenue for First Quarter 2020 and Provides Business Update in Response to COVID-19 Pandemic Business Wire
Mar-25-20 11:30AM	Intersect ENT (XENT) Down 49.5% Since Last Earnings Report: Can It Rebound? Zacks +9.40%
Mar-18-20 05:28PM	XENT Long Term Shareholder Alert: Johnson Fistel Investigates Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses? GlobeNewswire -5.29%
07:57AM	Insider Buying: The Intersect ENT, Inc. (NASDAQ:XENT) Executive VP & CFO Just Bought US$125k Worth Of Shares Simply Wall St.
Mar-16-20 09:38AM	New Strong Sell Stocks for March 16th Zacks -40.14%
Mar-04-20 09:48AM	Intersect ENT Down on Low Propel Sales, Pricing Pressure Zacks -5.15%
Mar-02-20 08:48AM	Edited Transcript of XENT earnings conference call or presentation 24-Feb-20 1:00pm GMT Thomson Reuters StreetEvents
Mar-01-20 10:55AM	XENT Alert: Johnson Fistel Continues Investigation of Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses? PR Newswire
Feb-28-20 08:59AM	Implied Volatility Surging for Intersect ENT (XENT) Stock Options Zacks +8.95%
Feb-25-20 09:28AM	Intersect ENT (XENT) Reports Narrower-Than-Expected Q4 Loss Zacks
Feb-24-20 08:15AM	Intersect ENT (XENT) Reports Q4 Loss, Tops Revenue Estimates Zacks -8.89%
07:00AM	Intersect ENT Reports Fourth Quarter and Full Year 2019 Results Business Wire
06:00AM	Intersect ENT, Inc. to Host Earnings Call ACCESSWIRE
Feb-17-20 12:30PM	Earnings Preview: Intersect ENT (XENT) Q4 Earnings Expected to Decline Zacks
Feb-05-20 04:05PM	Intersect ENT to Report Fourth Quarter and Year 2019 Financial Results Business Wire
04:05PM	Intersect ENT to Present at the 9th Annual SVB Leerink Global Healthcare Conference Business Wire
Jan-23-20 10:48AM	New Product Suite Boosts Intersect ENT Despite Cost Concerns Zacks
Jan-14-20 05:43AM	Did Intersect ENT's (NASDAQ:XENT) Share Price Deserve to Gain 83%? Simply Wall St.
04:41AM	Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings? Zacks
Jan-13-20 10:16AM	Can New Strategic Efforts Aid Apharia's (APHA) Q2 Earnings? Zacks +5.02%
08:14AM	Can Cannabis Therapy Drive Aphria's (APHA) Q2 Earnings? Zacks
07:00AM	Intersect ENT Reports Preliminary Full Year 2019 Revenue Business Wire
Dec-31-19 10:45AM	Here's Why You Should Hold on to Intersect ENT (XENT) for Now Zacks
Dec-24-19 11:21AM	Product Launches Aid Intersect ENT (XENT) Despite Cost Woes Zacks
Dec-12-19 10:25AM	Intersect ENT (XENT) Grows on Innovation Despite Cost Woes Zacks
Dec-11-19 04:05PM	Intersect ENT to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-08-19 07:27PM	Is Intersect ENT Inc (XENT) A Good Stock To Buy? Insider Monkey
Dec-04-19 04:05PM	SI-BONE Names Jeryl (Jeri) Hilleman to Board of Directors GlobeNewswire
Dec-01-19 09:30AM	Why Is Intersect ENT (XENT) Up 21.7% Since Last Earnings Report? Zacks
Nov-27-19 07:00AM	Intersect ENT Announces Appointment of New Chief Financial Officer TEST Business Wire Releases
07:00AM	Intersect ENT Announces Appointment of New Chief Financial Officer Business Wire
Nov-19-19 04:05PM	Intersect ENT to Present at the 31st Annual Piper Jaffray Healthcare Conference Business Wire
Nov-14-19 01:08PM	Edited Transcript of XENT earnings conference call or presentation 1-Nov-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-12-19 08:58AM	The Chief Commercial Officer of Intersect ENT, Inc. (NASDAQ:XENT), Robert Binney, Just Sold 100% Of Their Holding Simply Wall St.
Nov-04-19 09:53AM	Intersect ENT (XENT) Reports Q3 Loss, Revenues Meet Estimates Zacks

Intersect ENT, Inc., a drug delivery company, researches and develops products for the treatment of patients with ear, nose, and throat conditions in the United States. The company offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MOLL FREDERIC H	Director	Jan 19	Option Exercise	0.72	12,500	9,000	260,961	Feb 05 06:53 PM
West Thomas A.	President and CEO	Mar 17	Buy	8.48	19,035	161,434	236,890	Mar 18 04:59 PM
MEIER RICHARD A	EVP & Chief Financial Officer	Mar 17	Buy	7.80	5,000	38,997	124,471	Mar 17 08:37 PM
MEIER RICHARD A	EVP & Chief Financial Officer	Mar 16	Buy	12.55	10,000	125,462	119,471	Mar 17 06:02 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience